Comparison of intensive insulin therapy and conventional glucose management in patients undergoing coronary artery bypass grafting

被引:3
|
作者
Mohod, Vaishali [1 ]
Ganeriwal, Veena [1 ]
Bhange, Juilee [1 ]
机构
[1] Grant Med Coll & Sir JJ Grp Hosp, Dept Anaesthesiol & Crit Care, Mumbai, Maharashtra, India
关键词
Coronary artery bypass grafting; glycemic control; intensive insulin therapy; CARDIAC-SURGERY; NONDIABETIC PATIENTS; GLYCEMIC CONTROL; DIABETICS; MORTALITY;
D O I
10.4103/joacp.JOACP_61_17
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Aims: Hyperglycemia during cardiac surgery is a risk factor for postoperative outcomes. Because incidence of diabetes mellitus is increasing in Indian population, we tried to evaluate the western protocol for strict control of blood sugar perioperatively. The main aim of the study was to evaluate glycemic control during coronary artery bypass grafting and to determine whether intensive insulin therapy (IIT) is better than the conventional one. Material and Methods: A prospective randomized comparative study was conducted to evaluate IIT and conventional management of glucose in 40 patients undergoing on-pump coronary artery bypass grafting. Outcomes measured were incidence of hyperglycemia or hypoglycemia, incidence of hypokalemia, prolonged intubation, wound infections, strokes, acute renal failure, new onset arrhythmias, length of stay in ICU and hospital, cardiac arrest and mortality. The statistical analysis was done by using Chi-square test, and paired and unpaired t test. Results: The diabetic patients had significantly higher mean blood sugar and insulin requirement. The incidence of hyperglycemia was significantly higher in conventional management of blood sugar (P = 0.001), whereas hypoglycemia (P = 0.047) and hypokalemia (P = 0.020) were significantly higher in IIT. There were no significant difference in the incidence of prolonged intubation, wound infection, length of ICU and hospital stay, strokes, acute renal failure, new onset arrhythmias, cardiac arrest, and mortality. Conclusion: The IIT did not improve the morbidity and mortality in our patients undergoing coronary artery bypass grafting.
引用
收藏
页码:493 / 497
页数:5
相关论文
共 50 条
  • [1] A comparison of clonidine with conventional preanesthetic medication in patients undergoing coronary artery bypass grafting
    Thomson, IR
    Peterson, MD
    Hudson, RJ
    ANESTHESIA AND ANALGESIA, 1998, 87 (02): : 292 - 299
  • [2] Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery
    Gustafson, PA
    Zarro, DL
    Palanzo, DA
    Manley, NJ
    Montesano, RM
    Quinn, M
    Elmore, BA
    Castagna, JM
    PERFUSION-UK, 2002, 17 (02): : 141 - 144
  • [3] Cardioprotective Effects of Glucose and Insulin Administration While Maintaining Normoglycemia (GIN Therapy) in Patients Undergoing Coronary Artery Bypass Grafting
    Carvalho, George
    Pelletier, Patricia
    Albacker, Turki
    Lachapelle, Kevin
    Joanisse, Denis R.
    Hatzakorzian, Roupen
    Lattermann, Ralph
    Sato, Hiroaki
    Marette, Andre
    Schricker, Thomas
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (05): : 1469 - 1477
  • [4] Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting
    Barakat, Amr F.
    Saad, Marwan
    Abuzaid, Ahmed
    Mentias, Amgad
    Mahmoud, Ahmed
    Elgendy, Islam Y.
    ANNALS OF THORACIC SURGERY, 2016, 101 (02): : 818 - 825
  • [5] Management of patients with hematological malignancies undergoing coronary artery bypass grafting
    Borde, Deepak
    Gandhe, Uday
    Hargave, Neha
    Pandey, Kaushal
    ANNALS OF CARDIAC ANAESTHESIA, 2013, 16 (01) : 47 - 50
  • [6] Management of Iatrogenic Pseudoaneurysms in Patients Undergoing Coronary Artery Bypass Grafting
    Stone, Patrick A.
    Thompson, Stephanie N.
    Hanson, Brent
    Masinter, David
    VASCULAR AND ENDOVASCULAR SURGERY, 2016, 50 (04) : 217 - 220
  • [7] Intensive insulin therapy does not change the inflammatory response in non-diabetic patients undergoing elective coronary artery bypass grafting
    C Hoedemaekers
    P Pickkers
    M Netea
    M van Deuren
    J van der Hoeven
    Critical Care, 9 (Suppl 1):
  • [8] Statin Therapy in Patients Undergoing Coronary Artery Bypass Grafting for Acute Coronary Syndrome
    Liakopoulos, Oliver J.
    Kuhn, Elmar W.
    Slottosch, Ingo
    Thielmann, Matthias
    Wendt, Daniel
    Kuhr, Kathrin
    Jakob, Heinz
    Wahlers, Thorsten
    THORACIC AND CARDIOVASCULAR SURGEON, 2018, 66 (06): : 434 - 441
  • [9] Vorapaxar in Patients Undergoing Coronary Artery Bypass Grafting
    Ben-Yehuda, Ori
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (11) : 1058 - 1060
  • [10] MANAGEMENT OF PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING IN THE EARLY POSTOPERATIVE PERIOD
    Musayev, S. A.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 85 (03): : 153 - 156